BRASILIA. KAZINFORM Brazil’s national drug authority Anvisa on Wednesday (Mar. 30) granted emergency authorization to COVID-19 treatment drug Paxlovid, a combination of nirmatrelvir and ritonavir. The product is manufactured by pharmaceutical company Wyeth.